Adam de Havenon
Overview
Explore the profile of Adam de Havenon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
253
Citations
1934
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson I, Brigger H, Smith J, Peasley E, Champagne A, Littig L, et al.
AJNR Am J Neuroradiol
. 2025 Mar;
PMID: 40081846
Background And Purpose: Portable MRI (pMRI) has emerged as a cost-effective and accessible tool for the identification of white matter hyperintensities (WMH), an independent risk factor for stroke and dementia....
2.
Wu K, Huo S, Rivier C, Torres-Lopez V, Sharma R, de Havenon A, et al.
medRxiv
. 2025 Mar;
PMID: 40061328
Background And Objectives: Polygenic susceptibility to hypertension and diabetes negatively impacts the clinical trajectory of ischemic stroke survivors. We hypothesize that polygenic susceptibility to hyperlipidemia (PSH) negatively impacts cholesterol control...
3.
Forman R, Xin X, Kim C, Kernan W, Sheth K, Krumholz H, et al.
J Hypertens
. 2025 Feb;
43(4):715-718.
PMID: 39995224
The objective of this report is to characterize BP control among patients six months post stroke and measure time to first visit. Patients were discharged from the Yale New Haven...
4.
King A, Tan X, Dhopeshwarkar N, Bohn R, Dea K, Leonard C, et al.
Am J Prev Cardiol
. 2025 Feb;
21:100922.
PMID: 39896054
Introduction: Limited data exist on the cardiovascular effectiveness of once-weekly (OW) glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in real-world practice. Methods: We assessed the OW GLP-1 RA effects on vascular...
5.
Rivier C, Szejko N, Renedo D, Clocchiatti-Tuozzo S, Huo S, de Havenon A, et al.
Nat Commun
. 2025 Feb;
16(1):1261.
PMID: 39893209
Chronological age is an imperfect estimate of molecular aging. Epigenetic age, derived from DNA methylation data, provides a more nuanced representation of aging-related biological processes. We examine the bidirectional relationship...
6.
Gordon-Kundu B, Peyravi R, Garg A, Baker A, Salas S, Levien M, et al.
J Am Heart Assoc
. 2024 Dec;
14(2):e033365.
PMID: 39699007
Background: Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic cardiovascular disease, including acute ischemic stroke (AIS), due to large- and small-vessel disease. Cholesterol management guidelines recommend lipid-lowering therapy...
7.
Inzucchi S, Tan X, Liang Y, Yedigarova L, Xie L, de Havenon A
Diabetes Ther
. 2024 Dec;
16(2):187-203.
PMID: 39688779
Introduction: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have demonstrated cardiovascular benefits in trials involving high-risk patients with type 2 diabetes (T2D), while dipeptidyl peptidase 4 inhibitors (DPP-4is) have not....
8.
How Much More Time Neurologic Examination Adds to Outpatient Visits: A Study of Cross-Sectional Data
Ney J, Wilson A, Raphaelson M, de Havenon A
Neurol Clin Pract
. 2024 Dec;
15(1):e200404.
PMID: 39649023
Background And Objectives: The neurologic examination is a key part of neurologist visits. The neurologic examination leads to more accurate diagnoses, avoidance of unnecessary tests and procedures, and a stronger...
9.
Zabinska J, de Havenon A, Sheth K
Curr Opin Neurol
. 2024 Dec;
38(1):35-39.
PMID: 39624032
Purpose Of Review: This review aims to describe recent advances in low-field (0.064 T) magnetic resonance imaging (LF-MRI) of cerebrovascular disease, including ischemic and hemorrhagic stroke and white matter hyperintensities....
10.
Sorby-Adams A, Guo J, Laso P, Kirsch J, Zabinska J, Garcia Guarniz A, et al.
Nat Commun
. 2024 Dec;
15(1):10488.
PMID: 39622805
Portable, low-field magnetic resonance imaging (LF-MRI) of the brain may facilitate point-of-care assessment of patients with Alzheimer's disease (AD) in settings where conventional MRI cannot. However, image quality is limited...